C

CytoTools AG
XETRA:T5O

Watchlist Manager
CytoTools AG
XETRA:T5O
Watchlist
Price: 101.26 EUR 0.98%
Market Cap: 52.8m EUR
Have any thoughts about
CytoTools AG?
Write Note

Net Margin
CytoTools AG

-3 221.4%
Current
-6 281%
Average
-7.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-3 221.4%
=
Net Income
-660.7k
/
Revenue
20.5k

Net Margin Across Competitors

Country DE
Market Cap 52.8m EUR
Net Margin
-3 221%
Country US
Market Cap 333.6B USD
Net Margin
10%
Country US
Market Cap 173B USD
Net Margin
10%
Country US
Market Cap 124.8B USD
Net Margin
-5%
Country US
Market Cap 111.1B USD
Net Margin
32%
Country US
Market Cap 108.5B USD
Net Margin
4%
Country US
Market Cap 94.1B EUR
Net Margin
-392%
Country AU
Market Cap 145.3B AUD
Net Margin
18%
Country US
Market Cap 39.3B EUR
Net Margin
-33%
Country US
Market Cap 38B USD
Net Margin
-3%
Country KY
Market Cap 248.5B CNY
Net Margin
-20%

Profitability Report

View the profitability report to see the full profitability analysis for CytoTools AG.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-3 221.4%
=
Net Income
-660.7k
/
Revenue
20.5k
What is the Net Margin of CytoTools AG?

Based on CytoTools AG's most recent financial statements, the company has Net Margin of -3 221.4%.